Belvedere Trading’s Celgene Corp CELG Stock Holding History

Belvedere Trading’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-18,000	Closed	-$2.01M	–	433
2014 Q4	$2.01M	Buy	+18,000	New	+$1.9M	0.02%	63

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Belvedere Trading's CELG Position: Q1 2015 in Review

Belvedere Trading sold out of Celgene Corp (CELG) in Q1 2015, closing a stake of 18,000 shares — an estimated $2.01M sold.

Belvedere Trading first reported a position in CELG in Q4 2014 and held it in 1 quarter. The position peaked at $2.01M in Q4 2014. 1,193 funds tracked by Wall St. Rank hold CELG as of Q1 2015.

Belvedere Trading reported no remaining Celgene Corp position as of Q1 2015 after selling out during the quarter.
Belvedere Trading sold 18,000 Celgene Corp shares in Q1 2015, an estimated $2.01M.
Belvedere Trading first reported a position in Celgene Corp in Q4 2014 and held it in 1 quarter.
Belvedere Trading's Celgene Corp position peaked at $2.01M in Q4 2014.
1,193 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2015.

Based on Belvedere Trading's 13F filing for Q1 2015, filed 14 May 2015.